Dexcom Ventures
Signal active
Investment Firm
Overview
The inaugural fund will seek to identify and invest in opportunities to supplement growth in the core business and advance the development of adjacent technologies for the future.
Highlights
Founded
2021
Industry
Employees
1-10
Investment
5
Lead Investment
1
Exits
undefined
Stages
Early Stage Venture, Seed
Investor Type
Corporate Venture Capital
Location
San Diego, California, United States, North America
Contact Information
Social
Profile Resume
Dexcom Ventures, established in 2021 and headquartered in United States, North America., specializes in Early Stage Venture, Seed investments across Machine Learning, Health Care, Financial Services, Venture Capital, Finance, Security, Medical Device, Biotechnology, Medical, Wearables. Their recent investments include Signos, Google Ventures, MedCrypt, Nutromics, Artesian VC. The highest investment round they participated in was $4.0B. Among their most notable exits are Signos and Google Ventures. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Employees
N/A
Investment portfolio
Dexcom Ventures has made 5 investments. Their most recent investment was on Oct 21, 2023, when Signos raised $20.0M.
investments
5
Diversity investments
0
Lead investments
1
Number of exits
undefined
Investments
5
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Feb 16, 2022 | Epitel | Health Care | 12.5M |
| Sep 08, 2022 | Nutromics | Biotechnology | 14.0M |
| Jan 24, 2023 | MedCrypt | Security | null |
| Oct 21, 2023 | Signos | Machine Learning | 20.0M |
MedCryptExits
0
Funding Timeline
Funding rounds
5
Investors
0
Funds
0
Funding Rounds
5
Dexcom Ventures has raised 5 rounds. Their latest funding was raised on Oct 21, 2023 from a Series B - Signos round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Feb 16, 2022 | Series A - Epitel | - | 12.5M | - |
| Sep 08, 2022 | Seed Round - Nutromics | - | 14.0M | - |
| Jan 24, 2023 | Series B - MedCrypt | - | 0 | - |
| Oct 21, 2023 | Series B - Signos | - | 20.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
N/A
Recent Activity
Funding Round
Oct 21, 2023
Signos raised $20000000 on 2023-10-21 in Series B
Funding Round
Jan 24, 2023
MedCrypt raised an undisclosed amount on 2023-01-24 in Series B
Funding Round
Sep 08, 2022
Nutromics raised $14000000 on 2022-09-08 in Seed Round
Funding Round
Feb 16, 2022
Epitel raised $12500000 on 2022-02-16 in Series A
Funding Round
Nov 10, 2021
Signos raised $13000000 on 2021-11-10 in Series A